InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Otto Dawn Parsell, Vice-Président Exécutif. Insider active across 1 companies, notably Tricida, Inc.. Aggregated, 2 reports have been recorded. The latest transaction was disclosed on 31 December 2021 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€13,2871,574 shares@ €8.4415100.0% of flow
Common Stock
SEC:0001595585-22-000004·
€13,2871,574 shares@ €8.441550.0% of flow
Common Stock
SEC:0001595585-22-000004:0·
2 of 2 declarations
About Otto Dawn Parsell
Dawn Parsell Otto is the Executive Vice President of Clinical Development at Tricida, Inc. She is responsible for overseeing the company's clinical development programs and research strategy. Her expertise in the pharmaceutical field and experience in clinical project management are essential for the success of Tricida's initiatives. Dawn Otto is committed to advancing innovation in the healthcare sector.
